ampk glp 1 GLP-1 Receptor Agonist and Non-Alcoholic Fatty Liver Disease 1 activation The metabolite GLP‐1 (9‐36) is

Zepbound: Designated as a weight loss treatment for adults with obesity or who are overweight with related health conditions, and for moderate to severe obstructive sleep apnea (OSA)

Starting at the lower end of dosing ranges (20-30 mcg) and assessing response before increasing is advisable

Elevated homocysteine levels in the blood (i.e., hyperhomocysteinemia) may be a risk factor for cardiovascular disease and could also be linked to dementia and Alzheimers disease (20, 21)

Over time, oxidative stress, inflammation, and disease risk increase

This offers a proactive, complementary option for addressing the demands of living with CHF

Insulin Glargine (Lantus) : A long-acting insulin analog where asparagine at position A21 is replaced by glycine, and two arginines are added to the C-terminus of the B chain